El año pasado, Clearpoint Neuro Inc generó 14.83M USD en su segmento con mejor rendimiento, Products: Functional neurosurgery. United States realizó la mayor aportación, representando 36.97M USD el año pasado. Para el último trimestre, Clearpoint Neuro Inc reportó unos ingresos de 5.55M USD para el periodo finalizado el 2026-06-30, procedentes del segmento con mejor rendimiento, Products: Functional neurosurgery. United States aportó los mayores ingresos, alcanzando los 10.88M USD.

Por negocio

Ingresos operativos

Proporción

Anual

Anual

Trimestral

Products: Functional neurosurgery

Services: Biologics and drug delivery

Products: Biologics and drug delivery

Product Systems and software products

Services: Capital equipment and other

Services -Functional neurosurgery navigation and therapy

Products: Capital equipment

Services Therapy

Products:Therapy

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

Products: Functional neurosurgery

14.83M(40.12%)

10.29M(32.77%)

7.59M(31.68%)

7.59M(36.92%)

7.70M(47.22%)

6.27M(48.88%)

6.88M(61.37%)

Services: Biologics and drug delivery

11.70M(31.65%)

11.70M(37.29%)

11.45M(47.79%)

5.43M(26.42%)

3.44M(21.12%)

3.58M(27.87%)

889.70K(7.93%)

Products: Biologics and drug delivery

7.34M(19.85%)

5.61M(17.86%)

2.15M(8.99%)

3.69M(17.96%)

3.35M(20.57%)

1.47M(11.44%)

1.46M(13.01%)

Product Systems and software products

1.69M(4.57%)

2.73M(8.71%)

860.00K(3.59%)

1.51M(7.36%)

864.00K(5.30%)

440.00K(3.43%)

--(--)

Services: Capital equipment and other

1.41M(3.81%)

1.06M(3.38%)

973.00K(4.06%)

795.00K(3.87%)

569.00K(3.49%)

1.05M(8.18%)

625.87K(5.58%)

Services -Functional neurosurgery navigation and therapy

--(--)

931.00K(3.89%)

1.54M(7.48%)

375.00K(2.30%)

25.00K(0.19%)

--(--)

Products: Capital equipment

--(--)

1.04M(9.24%)

Services Therapy

--(--)

225.00K(2.01%)

Products:Therapy

--(--)

96.92K(0.86%)

Por región

Ingresos operativos

Proporción

Anual

Anual

Trimestral

United States

FY2025

FY2024

FY2023

United States

36.97M(100.00%)

31.39M(100.00%)

23.95M(100.00%)